Patents by Inventor Brett Paterson

Brett Paterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cage amine ligands for metallo-radiopharmaceuticals
    Patent number: 9861714
    Abstract: The present invention relates to compounds that are useful as metal ligands and which can be bound to a biological entity such as a molecular recognition moiety and methods of making these compounds. Once the compounds that are bound to a biological entity are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilizing the radiolabelled compounds of the invention.
    Type: Grant
    Filed: August 18, 2016
    Date of Patent: January 9, 2018
    Assignee: The University of Melbourne
    Inventors: Paul Donnelly, Brett Paterson
  • CAGE AMINE LIGANDS FOR METALLO-RADIOPHARMACEUTICALS
    Publication number: 20160354497
    Abstract: The present invention relates to compounds that are useful as metal ligands and which can be bound to a biological entity such as a molecular recognition moiety and methods of making these compounds. Once the compounds that are bound to a biological entity are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilising the radiolabelled compounds of the invention.
    Type: Application
    Filed: August 18, 2016
    Publication date: December 8, 2016
    Inventors: Paul Donnelly, Brett Paterson
  • Cage amine ligands for metallo-radiopharmaceuticals
    Patent number: 9457107
    Abstract: The present invention relates to compounds that are useful as metal ligands and which can be bound to a biological entity such as a molecular recognition moiety and methods of making these compounds. Once the compounds that are bound to a biological entity are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilizing the radiolabelled compounds of the invention.
    Type: Grant
    Filed: December 6, 2012
    Date of Patent: October 4, 2016
    Assignee: The University of Melbourne
    Inventors: Paul Donnelly, Brett Paterson
  • Functionalisation of cage amine ligands for metallo-radiopharmaceuticals
    Patent number: 9364570
    Abstract: The present invention relates to compounds that are useful as metal ligands and which contain a moiety capable of binding to a biological entity and methods of making these compounds. These compounds are of interest as they can be bound to a biological entity and then coordinated with a suitable metallic radionuclide. The coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging.
    Type: Grant
    Filed: December 6, 2012
    Date of Patent: June 14, 2016
    Assignee: The University of Melbourne
    Inventors: Paul Donnelly, Brett Paterson
  • FUNCTIONALISATION OF CAGE AMINE LIGANDS FOR METALLO-RADIOPHARMACEUTICALS
    Publication number: 20150051392
    Abstract: The present invention relates to compounds that are useful as metal ligands and which contain a moiety capable of binding to a biological entity and methods of making these compounds. These compounds are of interest as they can be bound to a biological entity and then coordinated with a suitable metallic radionuclide. The coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging.
    Type: Application
    Filed: December 6, 2012
    Publication date: February 19, 2015
    Applicant: The University of Melbourne
    Inventors: Paul Donnelly, Brett Paterson
  • CAGE AMINE LIGANDS FOR METALLO-RADIOPHARMACEUTICALS
    Publication number: 20140323718
    Abstract: The present invention relates to compounds that are useful as metal ligands and which can be bound to a biological entity such as a molecular recognition moiety and methods of making these compounds. Once the compounds that are bound to a biological entity are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilising the radiolabelled compounds of the invention.
    Type: Application
    Filed: December 6, 2012
    Publication date: October 30, 2014
    Inventors: Paul Donnelly, Brett Paterson